Combinatorial mutagenesis of MBNL1 zinc fingers elucidates distinct classes of regulatory events

Molecular and Cellular Biology

Volumn 32, Issue 20, 2012, Pages 4155-4167

  Purcell, Jamie ^a   Oddo, Julia C ^a   Wang, Eric T ^b   Berglund, J Andrew ^a  

^a UNIVERSITY OF OREGON   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA PRECURSOR; MUSCLEBLIND LIKE 1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BINDING AFFINITY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RNA BINDING; ZINC FINGER MOTIF;

EXONS; HELA CELLS; HUMANS; INTRONS; MUTAGENESIS; RNA SPLICING; RNA-BINDING PROTEINS; ZINC FINGERS;

EID: 84868709998     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00274-12     Document Type: Article

References (54)

1. Begemann GN, et al. 1997. muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. Development 124:4321-4331.
2. Black DL. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291-336.
3. Brook JD, et al. 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3= end of a transcript encoding a protein kinase family member. Cell 68:799-808.
4. Buckanovich RJ, Darnell RB. 1997. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell Biol. 17:3194-3201.
5. Cass D, et al. 2011. The four Zn fingers of MBNL1 provide a flexible platform for recognition of its RNA binding elements. BMC Mol. Biol. 12:20. doi:10.1186/1471-2199-12-20.
6. de Hoon MJL, Imoto S, Nolan J, Miyano S. 2004. Open source clustering software. Bioinformatics 20:1453-1454.
7. Du H, et al. 2010. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 17:187-193.
8. Fardaei M, Larkin K, Brook JD, Hamshere MG. 2001. In vivo colocalisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res. 29:2766-2771.
9. Fardaei M, et al. 2002. Three proteins, MBNL, MBLL and MBXL, colocalize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 11:805-814.
10. Fernandez-Costa JM, Llamusi MB, Garcia-Lopez A, Artero R. 2011. Alternative splicing regulation by Muscleblind proteins: from development to disease. Biol. Rev. Camb. Philos. Soc. 86:947-958.
11. Fu Y, Ramisetty SR, Hussain N, Baranger AM. 2012. MBNL1-RNA recognition: contributions of MBNL1 sequence and RNA conformation. Chembiochem 13:112-119.
12. Gates DP, Coonrod LA, Berglund JA. 2011. Autoregulated splicing of muscleblind-like 1 (MBNL1) pre-mRNA. J. Biol. Chem. 286:34224 -34233.
13. Goers ES, Purcell J, Voelker RB, Gates DP, Berglund JA. 2010. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res. 38:2467-2484.
14. Grammatikakis I, Goo Y-H, Echeverria GV, Cooper TA. 2011. Identification of MBNL1 and MBNL3 domains required for splicing activation and repression. Nucleic Acids Res. 39:2769-2780.
15. Han J, Cooper TA. 2005. Identification of CELF splicing activation and repression domains in vivo. Nucleic Acids Res. 33:2769-2780.
16. Hertel KJ. 2008. Combinatorial control of exon recognition. J. Biol. Chem. 283:1211-1215.
17. Hino S-I, et al. 2007. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum. Mol. Genet. 16:2834-2843.
18. Ho TH. 2004. Muscleblind proteins regulate alternative splicing. EMBO J. 23:3103-3112.
19. Ho TH, et al. 2005. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J. Cell Sci. 118:2923-2933.
20. House AE, Lynch KW. 2008. Regulation of alternative splicing: more than just the ABCs. J. Biol. Chem. 283:1217-1221.
21. Kosaki A, Nelson J, Webster NJ. 1998. Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA. J. Biol. Chem. 273:10331-10337.
22. Ladd AN, Charlet BN, Cooper TA. 2001. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell Biol. 21:1285-1296.
23. Lee JE, Cooper TA. 2009. Pathogenic mechanisms of myotonic dystrophy. Biochem. Soc. Trans. 37:1281-1286.
24. Licatalosi DD, et al. 2008. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456:464-469.
25. Lipscombe D. 2005. Neuronal proteins custom designed by alternative splicing. Curr. Opin. Neurobiol. 15:358-363.
26. Liquori CL, et al. 2001. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-867.
27. Liu H, Zhang W, Reed RB, Liu W, Grabowski PJ. 2002. Mutations in RRM4 uncouple the splicing repression and RNA-binding activities of polypyrimidine tract binding protein. RNA 8:137-149.
28. Llorian M, et al. 2010. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat. Struct. Mol. Biol. 17:1114-1123.
29. Lunde BM, Moore C, Varani G. 2007. RNA-binding proteins: modular design for efficient function. Nat. Rev. Mol. Cell Biol. 8:479-490.
30. Mahadevan M, et al. 1992. Myotonic dystrophy mutation: an unstable CTG repeat in the 3= untranslated region of the gene. Science 255:1253-1255.
31. Mankodi A, et al. 2001. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 10:2165-2170.
32. Miller JW, et al. 2000. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J. 19: 4439-4448.
33. Modafferi EF, Black DL. 1997. A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon. Mol. Cell Biol. 17:6537-6545.
34. Musunuru K, Darnell RB. 2004. Determination and augmentation of RNA sequence specificity of the Nova K-homology domains. Nucleic Acids Res. 32:4852-4861.
35. Osborne RJ, et al. 2009. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum. Mol. Genet. 18:1471-1481.
36. Osborne RJ, Thornton CA. 2006. RNA-dominant diseases. Hum. Mol. Genet. 15:R162-R169.
37. Philips AV, Timchenko LT, Cooper TA. 1998. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737-741.
38. Ranum LPW, Cooper TA. 2006. RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci. 29:259-277.
39. Robinson F, Smith CWJ. 2006. A splicing repressor domain in polypyrimidine tract-binding protein. J. Biol. Chem. 281:800-806.
40. Saldanha AJ. 2004. Java Treeview-extensible visualization of microarray data. Bioinformatics 20:3246-3248.
41. Sawicka K, Bushell M, Spriggs KA, Willis AE. 2008. Polypyrimidinetract-binding protein: a multifunctional RNA-binding protein. Biochem. Soc. Trans. 36:641-647.
42. Sen S, et al. 2010. Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer. J. Biol. Chem. 285:25426-25437.
43. Spellman R, et al. 2005. Regulation of alternative splicing by PTB and associated factors. Biochem. Soc. Trans. 33:457-460.
44. Teplova M, et al. 2011. Protein-RNA and protein-protein recognition by dual KH1/2 domains of the neuronal splicing factor Nova-1. Structure 19:930-944.
45. Teplova M, Patel DJ. 2008. Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1. Nat. Struct. Mol. Biol. 15:1343-1351.
46. Ule J, et al. 2006. An RNA map predicting Nova-dependent splicing regulation. Nature 444:580-586.
47. Ule J, et al. 2005. Nova regulates brain-specific splicing to shape the synapse. Nat. Genet. 37:844-852.
48. Vicente-Crespo M, et al. 2008. Drosophila Muscleblind is involved in troponin T alternative splicing and apoptosis. PLoS One 3:e1613. doi: 10.1371/journal.pone.0001613.
49. Wang Z, Burge CB. 2008. Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14:802-813.
50. Warf MB, Berglund JA. 2007. MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T. RNA 13:2238-2251.
51. Witten JT, Ule J. 2011. Understanding splicing regulation through RNA splicing maps. Trends Genet. 27:89-97.
52. Xue Y, et al. 2009. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol. Cell 36:996-1006.
53. Yeo GW, et al. 2009. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 16:130-137.
54. Zhang C, et al. 2008. Defining the regulatory network of the tissuespecific splicing factors Fox-1 and Fox-2. Genes Dev. 22:2550-2563.